AZD4017   Click here for help

GtoPdb Ligand ID: 7695

Synonyms: AZD 4017 | AZD-4017
PDB Ligand
Compound class: Synthetic organic
Comment: AZD4017 is a selective inhibitor of 11-beta-hydroxysteroid dehydrogenase type 1 (11β-HSD1) [2-3]. This compound is listed in AstraZeneca's OpenInnovation Pharmacology Toolbox .
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 2
Rotatable bonds 9
Topological polar surface area 107.83
Molecular weight 419.22
XLogP 4.88
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCCSc1nc(ccc1C(=O)NC1CCCCC1)N1CCCC(C1)CC(=O)O
Isomeric SMILES CCCSc1nc(ccc1C(=O)NC1CCCCC1)N1CCC[C@H](C1)CC(=O)O
InChI InChI=1S/C22H33N3O3S/c1-2-13-29-22-18(21(28)23-17-8-4-3-5-9-17)10-11-19(24-22)25-12-6-7-16(15-25)14-20(26)27/h10-11,16-17H,2-9,12-15H2,1H3,(H,23,28)(H,26,27)/t16-/m0/s1
InChI Key NCDZABJPWMBMIQ-INIZCTEOSA-N
No information available.
Summary of Clinical Use Click here for help
AZD4017 was originally investigated as a potential treatment for cardiovascular and metabolic disorders, in particular diabetes. Click here to view AZD4017 trials registered with ClinicalTrials.gov.
Mechanism Of Action and Pharmacodynamic Effects Click here for help
Inhibition of 11β-HSD1 reduces circulating levels of the glucocorticoid, cortisol. Elevated levels of intracellular glucocorticoids are thought to underlie the metabolic syndrome [1] which can progress to type II diabetes [4-5].